RECOVER: Researching COVID to Enhance Recovery
Long COVID is real. Millions of people who had COVID-19 still have symptoms lasting months or years.
We created RECOVER to understand, diagnose, prevent, and treat Long COVID and help people who are suffering.
Learn about Long COVID
The RECOVER Initiative
Millions of Americans suffer from Long COVID. This disease affects each person differently, so no single research study can provide all the answers to Long COVID for everyone. The National Institutes of Health (NIH) created the RECOVER Initiative to find answers across many different types of research studies.
RECOVER brings together clinicians, scientists, caregivers, patients, and community members to understand, diagnose, prevent, and treat Long COVID. We’ve created the world’s most comprehensive and diverse group of Long COVID study participants.
We’re learning about Long COVID and testing different treatments. We’re sharing our research, quickly learning from it, adapting, and constantly refocusing our efforts to ease suffering for millions of people.
Together, we are working to understand, diagnose, prevent, and treat Long COVID.
Explore RECOVER’s progress and find out how to get involved:
RECOVER Research
Each RECOVER research team can use all RECOVER findings, data, and biosamples (small amounts of blood, saliva, and tissue, also known as biospecimens) to inform and improve their study. This way, we can learn more quickly about this complex condition and better understand, diagnose, prevent, and treat Long COVID.
Researchers study drugs, medical devices, or other approaches that may help relieve Long COVID symptoms.
Researchers study the health and symptoms of thousands of participants over several years. No treatments or medicines are provided.
Researchers study people who have died after having COVID, including people who did not have Long COVID.
Researchers use RECOVER data and biosamples (biospecimens) to answer new and important questions about Long COVID.
Researchers study biosamples (biospecimens) from people with and without Long COVID to understand how COVID affects different body systems.
Researchers study millions of digital medical records, called EHRs, to understand changes over time, learn who may have Long COVID, and learn how to treat or prevent it.
RECOVER Research
Each RECOVER research team can use all RECOVER findings, data, and biosamples (small amounts of blood, saliva, and tissue, also known as biospecimens) to inform and improve their study. This way, we can learn more quickly about this complex condition and better understand, diagnose, prevent, and treat Long COVID.
Researchers study drugs, medical devices, or other approaches that may help relieve Long COVID symptoms.
Researchers study the health and symptoms of thousands of participants over several years. No treatments or medicines are provided.
Researchers study people who have died after having COVID, including people who did not have Long COVID.
Researchers use RECOVER data and biosamples (biospecimens) to answer new and important questions about Long COVID.
Researchers study biosamples (biospecimens) from people with and without Long COVID to understand how COVID affects different body systems.
Researchers study millions of digital medical records, called EHRs, to understand changes over time, learn who may have Long COVID, and learn how to treat or prevent it.
RECOVER shares the data between the different types of research to understand, diagnose, prevent, and treat Long COVID.
RECOVER Enrollment
Clinical Trials
Observational Cohort Studies
Adult Cohort
Pediatric Cohort
Pregnancy Cohort
How Can I Participate?
Join a clinical trial
RECOVER-Treating Long COVID (RECOVER-TLC) is now enrolling participants in the next phase of RECOVER clinical trials. The REVERSE-LC study will test the safety and effectiveness of the drug barcitinib to help improve thinking and memory problems and reduce fatigue.
Provide feedback on the design of clinical trials
RECOVER-TLC invites members of the Long COVID community to review and comment on draft protocol synopses for upcoming clinical trials. These documents summarize the questions the study will investigate, how researchers will look for answers, and who is eligible to participate. Feedback will be accepted from registered public commenters during announced public comment periods. To receive notifications, gain access to drafts, and submit feedback, register through the RECOVER-TLC Collaborator Portal.
Share ideas for Long COVID treatment
RECOVER-TLC is accepting possible treatment ideas for symptoms of Long COVID. To date, more than 550 drugs, medical devices, and other therapies have been submitted, and 4 treatment ideas have been selected for the first round of RECOVER-TLC trials. Patients, caregivers, healthcare providers, researchers, and others can continue submitting ideas through the RECOVER-TLC Intervention Information Request Form.
Explore COVID-19 Resources
